ELI LILLY AND COMPAN

LLY

Delayed - 01/15 04:10:00 pm
190.77USD	+2.19%

Turn to zoom

Prev.	186.6900
Open	186.8000
High	191.7800
Low	186.8000
Volume	4 413 184

3h ago	Eli Lilly and : Lilly Confirms Date and Conference Call for Fourth-Quarter...
11h ago	Eli Lilly and Company : - Gabrielle Sulzberger Elected to Lilly Board of...
13h ago	Eli Lilly and : Lilly Invests $30 Million in Venture Fund for...
13h ago	Eli Lilly and : Invests $30 Million in Venture Capital Fund Targeting...

	Short Term	Mid-Term	Long Term
Trend	Bullish	Bullish	Bullish
Resistance	206	214	196
Spread/Res.	-7,3%	-11%	-2,7%
Spread/Supp.	21%	21%	24%
Support	158	158	154

Sales 2020	24 408 M - -
Net income 2020	5 802 M - -
Net Debt 2020	11 301 M - -
P/E ratio 2020	30,0x
Yield 2020	1,56%

Capitalization	173 B 173 B -
EV / Sales 2020	7,55x
EV / Sales 2021	6,63x
Nbr of Employees	33 625
Free-Float	99,8%

Eli Lilly and Company is engaged in drug manufacturing business. The Company discovers, develops, manufactures and markets products in two segments: human pharmaceutical products and animal health products. The Company's human pharmaceutical business segment sells medicines, which are discovered or...

>> Read more

Sector :

Pharmaceuticals - NEC

Calendar :

2021-01-29 Earnings Release

Trading Rating :

Investor Rating :

Mean consensus	OUTPERFORM
Number of Analysts	20
Average target price	181,58 $
Last Close Price	190,77 $
Spread / Highest target	19,0%
Spread / Average Target	-4,82%
Spread / Lowest Target	-37,1%